TD Cowen raised the firm’s price target on Insulet (PODD) to $379 from $324 and keeps a Buy rating on the shares. The firm said its target increase is based on its stellar 1Q and the April appointment of Ashley McEvoy as CEO who they think will continue to press on the year-to-date drivers of T2 growth.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PODD: